Our experience with Vinca alkaloids in the poly-chemotherapy of inoperable bronchopulmonary cancer
Mariani, R.; Bo de Stefanis, M.
Minerva Medica 61(33): 1777-1790
1970
ISSN/ISBN: 0026-4806 PMID: 5443242 Document Number: 28648
Document emailed within 1 workday
Related Documents
Aynillian, G.H.; Bell, C.L.; Farnsworth, N.R. 1974: Alkaloids of Vinca species. IV. NMR studies of herbamine and vincamajine. Corrected structure of herbamine, an alkaloid isolated from Vinca libanotica Lloydia 37(4): 589-592Wrbka, E.; Kondras, B. 1978: Reinforcement of the chemotherapy of inoperable bronchopulmonary neoplasms by proteolytic enzymes Wiener Medizinische Wochenschrift 128(5): 153-158
Valenti, S. 1973: Results of single- and multiple-drug treatment of 183 cases of inoperable bronchopulmonary cancer Polski Tygodnik Lekarski 28(14): 519-523
Rosdy, B. 1978: Use of fluorometry in the study of vinca alkaloids Acta Pharmaceutica Hungarica 48 Suppl: 34-37
Budman, D.R. 1992: New vinca alkaloids and related compounds Seminars in Oncology 19(6): 639-645
Danø, K.; Skovsgaard, T.; Nissen, N.I.; Friche, E.; Di Marco, A. 1983: Mechanism of resistance to anthracyclines and vinca alkaloids Progress in Clinical and Biological Research 132c: 231-246
Song, S.; Suzuki, H.; Terasaki, T.; Lemaire, M.; Sugiyama, Y. 1998: Modulation of the tumor disposition of vinca alkaloids by PSC 833 in vitro and in vivo Journal of Pharmacology and Experimental Therapeutics 287(3): 963-968
Gardiner, S.M.; Tomlinson, D.R.; Bennett, T. 1976: The in vitro and in vivo effects of vinca alkaloids on the noradrenergic innervation of the vas deferens Medical Biology 54(3): 193-202
Dano, K. 1972: Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo Cancer ChemoTherapy Reports 56(6): 701-708
Vachnadze, V.; Vachnadze, N.; Gogitidze, N.; Mushkiashvili, N.; Mchedlidze, K. 2017: Biologically Active Alkaloids from Rhizomes with Roots of Vinca Herbacea Waldst. et Kit, Growing in Georgia Georgian Medical News 271: 122-127
Koizumi, W.; Tanabe, S.; Higuchi, K.; Sasaki, T.; Nakayama, N.; Nagaba, S.; Azuma, M.; Shimoda, T.; Nishimura, K.; Nakatani, K.; Saigenji, K. 2004: Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(12): 1957-1961
Poisner, A.M.; Bernstein, J. 1971: A possible role of microtubules in catecholamine release from the adrenal medulla: effect of colchicine, vinca alkaloids and deuterium oxide Journal of Pharmacology and Experimental Therapeutics 177(1): 102-108
Masuda, N. 1997: Combination chemotherapy in the treatment of inoperable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(Suppl 3): 379-383
Pulatov, D.A. 2003: Palliative combined chemotherapy in patients with inoperable primary liver cancer Likars'ka Sprava 7: 67-70
Ostroverkhov, G.E.; Alimov, A.T. 1975: Certain results of the use of regional intra-arterial chemotherapy in inoperable cancer of the stomach Klinicheskaia Khirurgiia 7: 22-26
Hilselberger Kanitz, M.; Mastro, J.M.; Moore, R.E.; Starling, J.J. 1994: In vivo expression of P-glycoprotein in a human colon carcinoma xenograft is modulated by therapy with free and monoclonal antibody-conjugated vinca alkaloids Anticancer Research 14(3a): 857-868
Raevskiĭ, I.G. 1976: Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone Sovetskaia Meditsina 8: 112-114
Khodzhaev, V.G.; Ubaĭdullaev, K.U. 1971: The results of treating inoperable parotid gland cancer with regional intra-arterial chemotherapy Voprosy Onkologii 17(2): 82-85
Kochegarov, A.A.; Muratkhodzhaev, N.K.; Alimnazarov, S.A.; Bekirov, S.A. 1991: 20 years' experience in the use of local hyperthermia in the treatment of inoperable cancer of the esophagus Voprosy Onkologii 37(7-8): 856-860
Fukuoka, M.; Takada, M.; Kamei, T.; Negoro, S.; Kusunoki, Y.; Matsui, K.; Ryu, S.; Sakai, N.; Takifuji, N.; Masuda, N. 1987: Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 2): 871-880